New cyclodextrin-based nanocarriers for drug delivery and phototherapy using an irinotecan metabolite

E Einafshar, AH Asl, AH Nia, M Mohammadi… - Carbohydrate …, 2018 - Elsevier
SN38 is an active metabolite of irinotecan, which was approved for clinical use in metastatic
colorectal cancers. However, poor aqueous solubility and inactivation at pH below 6 are the …
被引用次数：53 相关文章 Web of Science: 49

New cyclodextrin-based nanocarriers for drug delivery and phototherapy using an irinotecan metabolite.

E Einafshar, AH Asl, AH Nia, M Mohammadi… - Carbohydrate …, 2018 - europepmc.org
SN38 is an active metabolite of irinotecan, which was approved for clinical use in metastatic
colorectal cancers. However, poor aqueous solubility and inactivation at pH below 6 are the …

New cyclodextrin-based nanocarriers for drug delivery and phototherapy using an irinotecan metabolite

E Einafshar, AH Asl, AH Nia… - Carbohydrate …, 2018 - pubmed.ncbi.nlm.nih.gov
SN38 is an active metabolite of irinotecan, which was approved for clinical use in metastatic
colorectal cancers. However, poor aqueous solubility and inactivation at pH below 6 are the …

[引用][C] New cyclodextrin-based nanocarriers for drug delivery and phototherapy using an irinotecan metabolite

E Einafshar, AH Asl, AH Nia, M Mohammadi… - 2018